FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/30/2024
Back to search
Official data from USPTO
MEBIUS PHARMACEUTICAL CO., LTD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
01/30/2024
Trademark type
Combined
Nice classes
3, 5
Filing date
02/25/2022
Registration date
10/03/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/03/2023
Last transaction
10/03/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
JP
Examiner
BERTRAND, JOSEPH
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "MEBIUS PHARMACEUTICAL CO., LTD" in orange.
Holders and representatives
Holders
Mebius Pharmaceutical Co., Ltd
Representatives
Kazuyo Morita Holland & Hart LLP
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Facial scrubs; facial washes; non-medicated toiletry preparations; gels for cosmetic purposes; beauty gels; make-up removing preparations; make-up removing creams; make-up removing gels; toners for cosmetic purposes; skin toners; cosmetic facial skin toners; cosmetic suntan lotions; sunscreen cream; cosmetic sunscreen preparations; sunscreen preparations for cosmetic purposes; beauty serums; beauty care cosmetics; non-medicated skin serums; facial peel preparations for cosmetic use; concealers for skin spots and blemishes; facial concealer; lipstick; eye shadow; eyeshadow palettes; foundation; liquid foundation; make-up foundation; long lash mascaras; eye liner; eyeliner pencils; eyebrow pencils; eyebrow cosmetics; cheek rouges; blush pencils; hair mascara; facial beauty masks; gel eye patches for cosmetic purposes; cosmetic patches containing sunscreen and sun block for use on the skin; bath crystals; non-medicated bath salts; cosmetics; perfume and flavour materialsessential oils
Class 5
Pharmaceutical products and preparations for chloasma; acne medications; medicated swabs; cotton swabs for medical use; dietary supplements with a cosmetic effect
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/06/2024
FIMP
FINAL DISPOSITION PROCESSED
01/06/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/03/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/20/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/18/2023
PUBO
PUBLISHED FOR OPPOSITION
07/18/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/28/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/12/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/12/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/12/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/12/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/12/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/12/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/25/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/24/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/24/2023
RFNT
REFUSAL PROCESSED BY IB
03/21/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/28/2023
RFRR
REFUSAL PROCESSED BY MPU
02/28/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/01/2023
CNRT
NON-FINAL ACTION WRITTEN
12/31/2022
DOCK
ASSIGNED TO EXAMINER
12/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
05/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/29/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/28/2022
Continuous trademark protection
Get notified about every new filing that threatens MEBIUS PHARMACEUTICAL CO., LTD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.